Department of Biomedical Engineering, Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands.
Medicinal Chemistry, Taros Chemicals GmbH & Co. KG, Emil-Figge-Straße 76a, 44227 Dortmund, Germany.
J Med Chem. 2021 Jun 24;64(12):8423-8436. doi: 10.1021/acs.jmedchem.1c00401. Epub 2021 Jun 2.
Protein-protein modulation has emerged as a proven approach to drug discovery. While significant progress has been gained in developing protein-protein interaction (PPI) inhibitors, the orthogonal approach of PPI stabilization lacks established methodologies for drug design. Here, we report the systematic ″bottom-up″ development of a reversible covalent PPI stabilizer. An imine bond was employed to anchor the stabilizer at the interface of the 14-3-3/p65 complex, leading to a molecular glue that elicited an 81-fold increase in complex stabilization. Utilizing protein crystallography and biophysical assays, we deconvoluted how chemical properties of a stabilizer translate to structural changes in the ternary 14-3-3/p65/molecular glue complex. Furthermore, we explore how this leads to high cooperativity and increased stability of the complex.
蛋白质-蛋白质相互作用(PPI)调节剂已被证实为一种药物研发方法。尽管在开发 PPI 抑制剂方面取得了显著进展,但 PPI 稳定化的正交方法在药物设计方面缺乏成熟的方法。在这里,我们报告了一种可还原共价 PPI 稳定剂的系统“自下而上”开发。亚胺键被用来将稳定剂锚定在 14-3-3/p65 复合物的界面上,形成一种分子胶,使复合物的稳定性提高了 81 倍。利用蛋白质晶体学和生物物理测定,我们剖析了稳定剂的化学性质如何转化为三元 14-3-3/p65/分子胶复合物的结构变化。此外,我们还探讨了这如何导致复合物的高协同性和稳定性增加。